Extrachromosomal driver mutations in glioblastoma and low-grade glioma

Nature Communications

Volumn 5, Issue , 2014, Pages

  Nikolaev, Sergey ^a   Santoni, Federico ^a,b   Garieri, Marco ^a   Makrythanasis, Periklis ^a,b   Falconnet, Emilie ^a   Guipponi, Michel ^b   Vannier, Anne ^b   Radovanovic, Ivan ^a,b   Bena, Frederique ^b   Forestier, Françoise ^b   Schaller, Karl ^a,b   Dutoit, Valerie ^b   Clement Schatlo, Virginie ^a,b   Dietrich, Pierre Yves ^b   Antonarakis, Stylianos E ^a,b,c  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Institute of Genetics and Genomics of Geneva (iGE3)   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; CIRCULAR DNA;

CANCER; CHROMOSOME; ENVIRONMENTAL CHANGE; ENZYME ACTIVITY; GERM CELL; MUTATION;

AMPLIFICATION LINKED EXTRACHROMOSOMAL MUTATION; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PATIENT; DOUBLE MINUTE GENE; ENVIRONMENTAL CHANGE; EXOME; GAIN OF FUNCTION MUTATION; GENE AMPLIFICATION; GENE SEQUENCE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MUTATION; ONCOGENE; TUMOR GENE; WILD TYPE; BRAIN TUMOR; CANCER GRADING; GENETICS; GENOMIC INSTABILITY; PATHOLOGY;

BRAIN NEOPLASMS; DNA, CIRCULAR; GENE AMPLIFICATION; GENOMIC INSTABILITY; GLIOBLASTOMA; GLIOMA; HUMANS; MUTATION; NEOPLASM GRADING;

EID: 84923320523     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6690     Document Type: Article

References (57)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011
2. Luo, J., Solimini, N. L. & Elledge, S. J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136, 823-837 (2009
3. Loeb, L. A., Springgate, C. F. & Battula, N. Errors in DNA replication as a basis of malignant changes. Cancer Res. 34, 2311-2321 (1974
4. Loeb, L. A., Bielas, J. H. & Beckman, R. A. Cancers exhibit a mutator phenotype: clinical implications. Cancer Res. 68, 3551-3557, discussion 3557 (2008
5. Loeb, L. A. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat. Rev. Cancer 11, 450-457 (2011
6. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546-1558 (2013
7. Cancer Genome Atlas, N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012
8. Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012
9. Nathanson, D. A. et al. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science 343, 72-76 (2014
10. Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462-477 (2013
11. Sanborn, J. Z. et al. Double minute chromosomes in glioblastoma multiforme are revealed by precise reconstruction of oncogenic amplicons. Cancer Res. 73, 6036-6045 (2013
12. Snuderl, M. et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20, 810-817 (2011
13. Cancer Genome Atlas, N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008
14. Ercan, D. et al. Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor. Oncogene 29, 2346-2356 (2010
15. Kong, A. et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471-475 (2012
16. Nikolaev, S. I. et al. Life-history traits drive the evolutionary rates of mammalian coding and noncoding genomic elements. Proc. Natl Acad. Sci. USA 104, 20443-20448 (2007
17. Carvalho, C. M. et al. Replicative mechanisms for CNV formation are error prone. Nat. Genet. 45, 1319-1326 (2013
18. Deem, A. et al. Break-induced replication is highly inaccurate. PLoS Biol. 9, e1000594 (2011
19. Malkova, A. & Haber, J. E. Mutations arising during repair of chromosome breaks. Annu. Rev. Genet. 46, 455-473 (2012
20. Costantino, L. et al. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science 343, 88-91 (2013
21. Storlazzi, C. T. et al. Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res. 20, 1198-1206 (2010
22. Shimizu, N. Molecular mechanisms of the origin of micronuclei from extrachromosomal elements. Mutagenesis 26, 119-123 (2011
23. Botchan, M. Hitchhiking without covalent integration. Cell 117, 280-281 (2004
24. Canute, G. W. et al. The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme. Neurosurgery 42, 609-616 (1998
25. Lundberg, G. et al. Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification. PLoS One 3, e3099 (2008
26. Lalic, H., Volavsek, C. & Radosevic-Stasic, B. Chromosomal instability and double minute chromosomes in a breast cancer patient. Acta Med. Okayama 58, 51-58 (2004
27. Nielsen, J. L. et al. Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer. Cancer Genet. Cytogenet. 65, 120-124 (1993
28. Von Hoff, D. D. et al. Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc. Natl Acad. Sci. USA 89, 8165-8169 (1992
29. Shimizu, N., Misaka, N. & Utani, K. Nonselective DNA damage induced by a replication inhibitor results in the selective elimination of extrachromosomal double minutes from human cancer cells. Genes Chromosomes Cancer 46, 865-874 (2007
30. Ambros, I. M. et al. Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation-sign of tumour cell revertance? Eur. J. Cancer 33, 2043-2049 (1997
31. Vogt, N. et al. Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc. Natl Acad. Sci. USA 101, 11368-11373 (2004
32. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643-649 (1998
33. Collis, S. J., DeWeese, T. L., Jeggo, P. A. & Parker, A. R. The life and death of DNA-PK. Oncogene 24, 949-961 (2005
34. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012
35. Yu, L. et al. Gemcitabine eliminates double minute chromosomes from human ovarian cancer cells. PLoS One 8, e71988 (2013
36. Quinn, L. A., Moore, G. E., Morgan, R. T. & Woods, L. K. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res. 39, 4914-4924 (1979
37. Bigner, S. H. & Vogelstein, B. Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol. 1, 12-18 (1990
38. Schulte, A. et al. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration. Clin Cancer Res. 18, 1901-1913 (2012
39. Szerlip, N. J. et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc. Natl Acad. Sci. USA 109, 3041-3046 (2012
40. Yost, S. E. et al. High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models. PLoS One 8, e56185 (2013
41. Bigner, S. H., Mark, J. & Bigner, D. D. Cytogenetics of human brain tumors. Cancer Genet. Cytogenet. 47, 141-154 (1990
42. Fischer, U. et al. A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma. Mol. Cancer Res. 6, 576-584 (2008
43. Phillips, J. J. et al. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathol. 23, 565-573 (2013
44. Del Rey, J. et al. Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors. BMC Cancer 10, 280 (2010
45. Gibaud, A. et al. Extrachromosomal amplification mechanisms in a glioma with amplified sequences from multiple chromosome loci. Hum. Mol. Genet. 19, 1276-1285 (2010
46. Su, F. et al. Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation. Cancer Res. 72, 969-978 (2012
47. Holland, E. C., Hively, W. P., DePinho, R. A. & Varmus, H. E. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 12, 3675-3685 (1998
48. Weiss, W. A. et al. Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res. 63, 1589-1595 (2003
49. Wei, Q. et al. High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model. Cancer Res. 66, 7429-7437 (2006
50. Corcoran, R. B. et al. EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov. 2, 227-235 (2012
51. Galli, R. et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021 (2004
52. Nikolaev, S. I. et al. A single-nucleotide substitution mutator phenotype revealed by exome sequencing of human colon adenomas. Cancer Res. 72, 6279-6289 (2012
53. Nikolaev, S. I. et al. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome. Blood 122, 554-561 (2013
54. Nikolaev, S. I. et al. Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. Nat. Commun. 5, 4654 (2014
55. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows- Wheeler transform. Bioinformatics 25, 1754-1760 (2009
56. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009
57. Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865-2871 (2009).